Alyssa Walker, PharmD, BCPS, BCIDP
Walker is an infectious diseases medical science liaison for bioMérieux. As an infectious diseases pharmacist with more than 10 years of clinical experience, she understands the complexities of managing and measuring an AMS program and the need for responsible applications of diagnostic technologies.
Articles
Antibiotic De-Escalation: Is This the Right Outcome Measure?
November 16th 2023The proposed clinical benefits of de-escalation has contributed to its lukewarm adoption in some settings. This article looks at the challenges in measuring the impact of de-escalation, and the ongoing search for more meaningful metrics to evaluate the success of antimicrobial stewardship (AMS) programs.
Read More
Latest Updated Articles
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: November 21st 2024 | Updated: November 23rd 2024
7-Day Antibiotic Regimen Found Noninferior to 14-Day Treatment for Bloodstream Infections
Published: November 18th 2024 | Updated: November 23rd 2024
Two Years After its FDA Approval, Rebyota Continues to Show Efficacy and Safety
Published: November 18th 2024 | Updated: November 23rd 2024
Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of Patients
Published: November 18th 2024 | Updated: November 23rd 2024
Challenges of Treating Patients With Staphylococcus aureus
Published: November 10th 2024 | Updated: November 23rd 2024
STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis
